Connect with us

Technology

Expert Speaker Line-Up Revealed for Industry-Leading RBQM Event

Published

2 weeks ago

on

CluePoints Supports Launch of RBQMLive 2024 as Premier Event Sponsor

KING OF PRUSSIA, Pa., Sept. 4, 2024 /PRNewswire/ — CluePoints, the premier sponsor of RBQMLive and provider of Risk-Based Quality Management (RBQM) and Data Quality Oversight Software, has revealed the full agenda and speaker line up for the award-winning RBQMLive event. RBQMLive is the industry-leading event for anyone working with, or interested in risk-based quality management approaches.

RBQMLive, taking place on September 24-25, 2024, is a free, virtual event offering attendees the opportunity to immerse themselves in cutting-edge discussions, workshops and networking opportunities. From transformative shifts in RBQM to global regulatory updates and the emergence of new technologies, this virtual event equips attendees with all they need to continue their RBQM journey and drive further efficiency gains across all clinical trials.

Last year’s event was attended by more than 1,000 delegates from over 375 organizations. RBQMLive 2024 is set to be even bigger and better with new opportunities to collaborate and drive positive change within the clinical trial landscape.

On day one, the keynote address, Unlocking the Path to RBQM Maturity, will again be delivered by Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development. Ken will explore evidence-based insights showcasing the increase in RBQM adoption, uncover factors driving and hindering RBQM usage and share actionable insights from the recent empirical research findings.

Other day one highlights include:

Taking RBQM into New Dimensions – Understanding the Risk-Based Data Management (RBDM) Revolution with Miguel Valenzuela, Associate Director of Clinical Operations, RBQM at Alnylam, Paul MacDonald, Senior Director Vault CDMS Strategy at Veeva and Patrick Nadonly, Global Head, Clinical Data Management, Sanofi.The Emergence of AI & ML in RBQM: What’s here now and what is to come? with Marcin Makowski, Head of Centralized Monitoring & Data Analytics, GSK and Bob Zambon, Vice President, Technology Strategy & Strategic Partnerships, Syneos Health.

Key themes on day two include the future of RBQM, enhanced data quality and optimizing study oversight. Highlights include:

RBQM Industry Guidance Evolution – Adapting to Modernization with Olivia Feiro, Director, Risk Management & Analytics at CSL Behring, Lotte Smets, Director of Data Management at Julius Clinical and Daniel DiJohnson, Risk-Based Quality Management SME, Senior Manager, Parexel.Enhancing Data Quality through Advanced Audit Trail Review with Paola Peshkepija, Senior Associate Central Monitor, Pfizer and Jennifer Nielsen, Senior Specialist, Clinical Data Management, Lundbeck.Integrated Data Review: Optimizing Study Oversight with Brian Barnes, Director of Risk Management Strategy – Process Excellence & Oversight at BioNTech, Jess Thompson, Founder of Clinical Research Project Management Association and Alaine Heffernan, Director Centralized Monitoring, Allucent.

Patrick Hughes, Co-Founder and Chief Commercial Officer of CluePoints, commented, “Risk-based quality management is evolving, and industry adoption is increasing fast. RBQMLive is a unique event which brings together global specialists, industry experts and anyone who is interested in finding out more about this transformative approach to managing clinical trials. This year’s exciting program looks set to make RBQMLive 2024 bigger and better than ever and we urge everyone to register for their free place.”

RBQMLive 2024 takes place virtually from September 24-25. Visit rbqmlive.com/rbqm-live-2024-agenda for more information and to register.

About CluePoints

CluePoints is the premier Risk-Based Quality Management (RBQM) and Data Quality Oversight Software provider. We are leveraging the potential of Artificial Intelligence using Advanced Statistics and Machine Learning to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R2), CluePoints is deployed to support central and on-site monitoring, medical review, quality risk management and to drive a holistic Risk-Based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls and solution implementation, you now have everything you need to adhere with global regulatory guidance. The result is positive clinical development outcomes, increased operational efficiency, lower costs and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.

 

View original content:https://www.prnewswire.co.uk/news-releases/expert-speaker-line-up-revealed-for-industry-leading-rbqm-event-302238051.html

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Dana-Farber Cancer Institute Partners with Clinical.ly to Enhance Regulatory Operations with eReg Solutions

Published

36 mins ago

on

September 19, 2024

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — The Dana-Farber Cancer Institute, a world leader in cancer treatment and research, chose Clinical.ly’s (www.clinical.ly) Research Suite™ to streamline regulatory operations, marking a significant step toward more efficient and compliant clinical trial management. Dana-Farber joins a growing number of research organizations that leverage Clinical.ly’s innovative solutions to streamline clinical trial processes. Clinical.ly’s eReg platform offers a comprehensive, paperless solution that centralizes regulatory workflows, ensuring compliance and transparency across clinical trials.

“We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO.

This partnership continues Clinical.ly’s success in providing best-in-class enterprise tools for conducting clinical research. “We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO. “Our eReg platform and wider set of features in Clinical.ly Research Suite™ will empower that renowned organization, and we all look forward to supporting their teams.”

About Clinical.ly Research Suite™ 

Clinical.ly Research Suite™ is a comprehensive solution that eliminates traditional, paper-based processes. By automating and centralizing essential workflows in the Clinical.ly Research Suite™, organizations achieve huge efficiency improvements, greater trial oversight, document management, and regulatory compliance. The Clinical.ly Research Suite™ includes:

eReg: A best-in-class electronic regulatory bindereSource: An intuitive & feature-rich, paperless data capture solution that streamlines data collection from trial participantseConsent: A fully digital solution for capturing informed consent, improving participant engagement and site complianceClinicallySign: 21 CFR Part 11 compliant eSignature functionalityClinicallyPay: A secure and instantaneous participant stipend payment and reimbursement solution

About Dana-Farber Cancer Institute

Founded in 1947, Dana-Farber Cancer Institute is committed to providing adults and children with the best treatment available today while developing tomorrow’s cures through cutting-edge research. Based in Boston, Dana-Farber is a teaching affiliate of Harvard Medical School and ranks consistently as one of the top cancer hospitals in the world.

About Clinical.ly

Clinical.ly provides differentiated, cloud-native technology solutions to the clinical research industry, enabling research organizations to conduct studies with greater efficiency and ease. Clinical.ly is dedicated to developing technology that eliminates tedious manual labor, allowing clinical research professionals to focus on patient care.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dana-farber-cancer-institute-partners-with-clinically-to-enhance-regulatory-operations-with-ereg-solutions-302253690.html

SOURCE Clinical.ly

Continue Reading

Technology

Fall Into Creativity with the Monport Laser Fall Sale

Published

36 mins ago

on

September 19, 2024

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — Experience laser innovation this Fall with Monport Laser, an industry frontrunner in laser engraving and cutting technology, with an exclusive Fall Sale offering incredible discounts and free accessories on a wide range of high-performance laser engraving machines. From September 19th to September 30th, customers can take advantage of this limited-time opportunity to elevate their laser engraving businesses with cutting-edge laser innovation at unbeatable prices.

Monport Laser has been dedicated to providing innovative and reliable laser machines that empower businesses and individuals to achieve their goals. With a focus on quality, precision, and customer satisfaction, Monport Laser has established itself as a trusted leader in the industry. Their commitment to excellence is evident in every laser they produce, ensuring exceptional performance, reliability, and value.

Embrace the Power of CO2 Laser Technology with Exclusive Offers

Monport Laser will offer two free accessories with selected CO2 laser machines during the Monport Fall sale. These versatile lasers are ideal for various applications, including engraving, cutting, and marking wood, acrylic, leather, and more. By taking advantage of this Fall sale, laser engraving businesses can enhance their productivity and expand their creative possibilities.

Experience Unmatched Value with Fiber Laser Discounts

Monport Laser offers substantial discounts of up to $4200 and 3 free accessories on selected models for those seeking the precision and speed of fiber laser technology. Fiber lasers are renowned for their ability to process metals with exceptional efficiency and accuracy, making them indispensable for metal fabrication, manufacturing, and jewelry production. Additionally, customers purchasing fiber lasers during the Fall sale will receive three free accessories, further sweetening the deal.

Elevate Your Desktop Laser Experience with a Free Water Chiller

Monport Laser is committed to providing comprehensive solutions for businesses of all sizes. As part of the Fall sale, customers who purchase the 40W Desktop laser will receive a Free Water Chiller Cw3000. This essential accessory ensures optimal cooling and performance, prolonging the lifespan of the laser and guaranteeing consistent results.

Discover Additional Savings on a Wide Range of Accessories

Monport Laser offers an additional 20% discount on selected accessories to complete your laser setup. From lenses and nozzles to rotary tables and smoke extraction systems, customers can find everything they need to maximize the potential of their laser machines.

Unleash Your Creativity and Productivity

Monport Laser’s Fall sale is the perfect opportunity to invest in laser technology that empowers your business or fuels your creative passions. With exceptional discounts and free accessories, you can acquire the ideal laser solution to meet your needs and budget.

Whether you’re an entrepreneur, artist, or manufacturer, Monport Laser’s advanced laser machines offer unparalleled precision, versatility, and reliability. Take advantage of this limited-time Fall sale and unlock your projects’ full potential for laser innovation.

About Monport Laser

Monport Laser is a global leader in designing, manufacturing, and distributing high-quality laser machines and accessories. With a commitment to innovation and customer satisfaction, Monport Laser provides cutting-edge solutions for various industries, including manufacturing, engraving, marking, and more.

For more information, visit monportlaser.com and follow them on social media for the latest updates.

Website: https://www.monportlaser.com/

 

 

 

View original content:https://www.prnewswire.com/news-releases/fall-into-creativity-with-the-monport-laser-fall-sale-302253699.html

SOURCE Monport Laser

Continue Reading

Technology

MEDIA ADVISORY – Minister Wilkinson to Make a Critical Minerals Infrastructure Announcement

Published

36 mins ago

on

September 19, 2024

By

VANCOUVER, BC, Sept. 19, 2024 /CNW/ – The Honourable Jonathan Wilkinson, Minister of Energy and Natural Resources, and Ranj Pillai, the Premier of Yukon, will make a funding announcement in support of critical minerals infrastructure projects. A media availability will follow.

Date: September 20, 2024

Time: 10:30 a.m. PT

All accredited media are asked to pre-register by emailing media@nrcan-rncan.gc.ca. A dial-in line is available for media and will be provided upon registration.

Follow us on LinkedIn

SOURCE Natural Resources Canada

Continue Reading

Trending